Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Marc, Kueng"'
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 316-320 (2017)
Brain and Head and neck metastases are rare in prostatic carcinoma patients. In this report we present a very uncommon case of the concomitant occurrence of a prostatic adenocarcinoma with neck metastases and an advanced laryngeal squamous cell carci
Externí odkaz:
https://doaj.org/article/b39ef77ce4e84e22aadef1fcdacb9e70
Autor:
Juerg Bernhard, Daniela Baertschi, Roger von Moos, Piercarlo Saletti, Alessandro Lugli, Christiane Andrieu, Luca Quagliata, Dieter Koeberle, Daniel Dietrich, Andreas Wicki, Sara Bastian, D. Helbling, Marc Kueng, Ralph Winterhalder, Dirk L. Kienle, Karin Ribi, Daniel Horber
Introduction While the anti-VEGF antibody bevacizumab was studied repeatedly as part of low-intensity regimens in less fit elderly patients with metastatic colorectal cancer (mCRC), anti-EGFR antibodies as upfront treatment modality have been scarcel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9435fde366a1de8ee992d3c70cb594
Autor:
Aurelius, Omlin, Martin, Spahn, Jörg, Beyer, Daniel, Eberli, Silke, Gillessen, Wolfram, Jochum, Marc, Kueng, Egbert, Nitzsche, Cyrill A, Rentsch, Enrico, Roggero, Hans-Peter, Schmid, Frank, Stenner, Arnoud J, Templeton, Damian, Wild, Stephen, Wyler, Daniel, Zwahlen, Richard, Cathomas
Publikováno v:
Praxis. 107(19)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8741620c1ee83787b2280b2aaef1c848
https://pubmed.ncbi.nlm.nih.gov/30227804
https://pubmed.ncbi.nlm.nih.gov/30227804
Autor:
Damian Wild, Hans-Peter Schmid, Jörg Beyer, Richard Cathomas, Martin Spahn, Silke Gillessen, Marc Kueng, Wolfram Jochum, Frank Stenner, Daniel R. Zwahlen, Arnoud J. Templeton, Cyrill A. Rentsch, Aurelius Omlin, Stephen Wyler, Egbert Nitzsche, Daniel Eberli, Enrico Roggero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937d905a77f2c30098cbbcab2682e817
https://www.zora.uzh.ch/id/eprint/158028/
https://www.zora.uzh.ch/id/eprint/158028/
Autor:
Marc Kueng, Pierre-Alain Tercier, Sandrine U Thalmann, Géraldine Risse, Bernhard Egger, Abdelkarim S. Allal, Peter A Kuhn, David Cédric Lauffer
Publikováno v:
Cureus
Background Non-resected locally advanced and microscopic positive-margin resected (R1) pancreatic adenocarcinoma are associated with a dismal prognosis. The combination of high dose radiotherapy and concomitant chemotherapy is among the strategies th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6dd511f77ec6c7d679964cf45434de8
https://doi.org/10.7759/cureus.2713
https://doi.org/10.7759/cureus.2713
Autor:
Marc Kueng, F. Rivera Herrero, Jose A. Lopez-Martin, Carmen Guillén-Ponce, J. Gallego Plazas, Manuel Benavides
Publikováno v:
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac3e6e79a315f278be6b67a7aca66a6
https://doi.org/10.1093/annonc/mdx369.141
https://doi.org/10.1093/annonc/mdx369.141
Autor:
Fernando Rivera, Jose A. Lopez-Martin, Marc Kueng, Manuel Benavides, Javier Gallego, Carmen Guillén-Ponce
Publikováno v:
Annals of Oncology. 28:iii72-iii73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb7b87f0508ae588573d68bcc6ce5d14
https://doi.org/10.1093/annonc/mdx261.198
https://doi.org/10.1093/annonc/mdx261.198
Autor:
Catherine Berset, Barbara Handschin, Bernhard C. Pestalozzi, Christine Biaggi Rudolf, Karin Ribi, Stephanie Rondeau, Josef Thaler, Pierre Oliver Bohanes, Marc Kueng, Peter Moosmann, Evelyn Rickenbacher, Ralph Winterhalder, Daniel Horber, Daniel Helbling, Jean-Marc Luthi, Viviane Hess, Stefanie Pederiva
Publikováno v:
Journal of Clinical Oncology. 36:TPS3621-TPS3621
TPS3621Background: Exercise has become a main focus of basic and clinical research worldwide during the current pandemic of physical inactivity. A clear link between inactivity and cancer incidence...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b04f58d649d01fdc7663194d0120d47
https://doi.org/10.1200/jco.2018.36.15_suppl.tps3621
https://doi.org/10.1200/jco.2018.36.15_suppl.tps3621
Autor:
Richard Herrmann, R. von Moos, Piercarlo Saletti, Attila Kollár, Markus Borner, Viviane Hess, Sandro Anchisi, K. Matter, Ralph Winterhalder, Marc Kueng, Peter Brauchli, Daniel Dietrich, M. Frueh, Daniela Baertschi, Dieter Koeberle, Arnaud Roth, Peter Moosmann, Sabina Schacher, Daniel Betticher, R. A. Popescu
Publikováno v:
Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollár, Attila; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V and Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of oncology, 26(4), pp. 709-714. Oxford University Press 10.1093/annonc/mdv011
Annals of Oncology, Vol. 26, No 4 (2015) pp. 709-14
Annals of Oncology, Vol. 26, No 4 (2015) pp. 709-14
In this trial, stopping bevacizumab after completion of induction chemotherapy was associated with a shorter time to progression, but no statistically significant difference in overall survival compared with the bevacizumab continuation strategy. Non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa47d1f07a0d51e80e0b758ebebd0839
https://boris.unibe.ch/77225/1/709.full.pdf
https://boris.unibe.ch/77225/1/709.full.pdf